Diagnostic Accuracy of ACR Ti-Rads in The Diagnosis of Thyroid Carcinoma in Solitary Thyroid Nodule Taking FNAC as Gold Standard
DOI:
https://doi.org/10.70749/ijbr.v3i7.1928Keywords:
Thyroid carcinoma, Solitary thyroid nodule, ACR Ti-RADS, Fine needle aspiration cytology, Diagnostic accuracyAbstract
Background: Thyroid carcinoma is a common malignancy with the solitary thyroid nodule (STN) being a significant risk factor. The American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (Ti-RADS) is widely used for thyroid nodule risk stratification. It is essential that its performance against the gold standard fine needle aspiration cytology (FNAC) is evaluated further. Objective: To assess Diagnostic accuracy of ACR Ti-Rads in the diagnosis of thyroid carcinoma in solitary thyroid nodule taking FNAC as gold standard. Study Design: Cross-sectional validation study. Duration and Place of Study: The study was conducted from February 2025 to May 2025 at the Department of Diagnostic Radiology, Shifa International Hospital, Islamabad. Methodology: We enrolled 423 patients aged between 18-65 with suspicious thyroid nodules. ACR Ti-RADS ultrasound and FNAC for all of them were performed. Sensitivity, specificity, positive predictive value (PPV), the negative predictive value (NPV), and diagnostic accuracy of ACR Ti-RADS were determined. A stratified analysis by age and sex was performed as well. Results: The study found that ACR Ti-RADS demonstrated high sensitivity (87.50%) and NPV (93.60%), with moderate specificity (59.20%) and diagnostic accuracy (66.20%). The study also showed differences in diagnostic performance based on age and gender, with younger patients and males exhibiting better specificity and diagnostic accuracy. Conclusion: ACR Ti-RADS is a reliable, non-invasive diagnostic tool for the detection of thyroid carcinoma in patients with solitary thyroid nodules, especially when used in combination with FNAC.
Downloads
References
1. Rehman AU, Ehsan M, Javed H, Ameer MZ, Mohsin A, Aemaz Ur Rehman M, et al. Solitary and multiple thyroid nodules as predictors of malignancy: a systematic review and meta-analysis. Thyroid Res 2022;15(1):22.
https://doi.org/10.1186/s13044-022-00140-6.
2. McQueen A, Al-Zuhir N, Ali T. Incidentalomas in the head & neck. Br J Radiol 2023;96(1142):20220164.
https://doi.org/10.1259/bjr.20220164.
3. AlSaedi AH, Almalki DS, ElKady RM. Approach to thyroid nodules: diagnosis and treatment. Cureus 2024;16(1):e52232.
https://doi.org/10.7759/cureus.52232.
4. Venkatesh N, Ho JT. Investigating thyroid nodules. Aust Prescr 2021;44(6):200-204.
https://doi.org/10.18773/austprescr.2021.055.
5. Tong J, Ruan M, Jin Y, Fu H, Cheng L, Luo Q, Liu Z, et al. Poorly differentiated thyroid carcinoma: a clinician's perspective. Eur Thyroid J 2022;11(2):e220021.
https://doi.org/10.1530/ETJ-22-0021.
6. Jung CK, Bychkov A, Kakudo K. Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach. Endocrinol Metab (Seoul) 2022;37(5):703-718.
https://doi.org/10.3803/EnM.2022.1553.
7. Metovic J, Cabutti F, Osella-Abate S, Orlando G, Tampieri C, Napoli F, et al. Clinical and pathological features and gene expression profiles of clinically aggressive papillary thyroid carcinomas. Endocr Pathol 2023;34(3):298-310.
https://doi.org/10.1007/s12022-023-09769-x.
8. Hu J, Yuan IJ, Mirshahidi S, Simental A, Lee SC, Yuan X. Thyroid carcinoma: phenotypic features, underlying biology and potential relevance for targeting therapy. Int J Mol Sci 2021;22(4):1950.
https://doi.org/10.3390/ijms22041950.
9. Rajyakodi K, Balasubramanian A, Sundaram S, Gnanavel H. Clinicopathological and radiological correlation among the spectrum of nodular thyroid lesions. Cureus 2024;16(10):e70725.
https://doi.org/10.7759/cureus.70725.
10. Alhassan R, Al Busaidi N, Al Rawahi AH, Al Musalhi H, Al Muqbali A, Shanmugam P, et al. Features and diagnostic accuracy of fine needle aspiration cytology of thyroid nodules: retrospective study from Oman. Ann Saudi Med 2022;42(4):246-251.
https://doi.org/10.5144/0256-4947.2022.246.
11. Gao L, Ma L, Li X, Liu C, Li N, Lian X, et al. Using preoperative ultrasound vascularity characteristics to estimate medullary thyroid cancer. Cancer Imaging 2023;23(1):64.
https://doi.org/10.1186/s40644-023-00583-6.
12. Sharafi SN, Moarefzadeh M, Moradi MT. The horizon of thyroid imaging reporting and data system in the diagnostic performance of thyroid nodules: clinical application and future perspectives. touchREV Endocrinol 2024;20(2):81-90.
https://doi.org/10.17925/EE.2024.20.2.11.
13. Pires AT, Mustafá AMM, Magalhães MOG. The 2017 ACR TI-RADS: pictorial essay. Radiol Bras 2022;55(1):47-53.
https://doi.org/10.1590/0100-3984.2020.0141.
14. Anwar K, Mohammad AY, Khan S. The sensitivity of TIRADS scoring on ultrasonography in the management of thyroid nodules. Pak J Med Sci 2023;39(3):870-874.
https://doi.org/10.12669/pjms.39.3.7313.
15. Grimmichová T, Pacesová P, Šbrová L, Vrbíková J, Havrdová T, Hill M. The gold standard of thyroid nodule examination? Prospective validation of the ACR TI-RADS in a secondary referral center. Physiol Res 2020;69(Suppl 2):S329-S337.
https://doi.org/10.33549/physiolres.934515
16. Kang YJ, Stybayeya G, Lee JE, Hwang SH. Diagnostic performance of ACR and Kwak TI-RADS for benign and malignant thyroid nodules: an update systematic review and meta-analysis. Cancers 2022;14(12):5961.
https://doi.org/10.3390/cancers14235961.
17. Hekimsoy İ, Öztürk E, Ertan Y, et al. Diagnostic performance rates of the ACR-TIRADS and EU-TIRADS based on histopathological evidence. Diagn Interv Radiol 2021;27:511-518.
https://doi.org/10.5152/dir.2021.20813.
18. Khatti SN, Soomro IA, Khan AGA, et al. Predictive value of fine needle aspiration cytology versus ultrasound TI-RADS in solitary thyroid nodule comparing with gold standard. J Popul Ther Clin Pharmacol 2024;31(7):233-238.
https://doi.org/10.53555/jptcp.v31i7.6926.
19. Nighat S, Zahra M, Javed AM, et al. Diagnostic accuracy of TI-RADS classification in differentiating benign and malignant thyroid nodules-a study from Southern Punjab, Pakistan. Biomedica 2021;37(3):159-163.
https://doi.org/10.51441.BioMedica.5-504.
20. Nasser IH, Aleem MA. Thyroid imaging reporting and data system (TIRADS) versus thyroid scan for solitary thyroid nodules. Med J Cairo Univ 2019;87(6):3789-3794.
21. Khan TB, Shaikh TA, Akram S, et al. Determination of diagnostic accuracy of ACR-TIRADS in detecting malignancy in thyroid nodules on ultrasonography, keeping Bethesda cytological score at FNAC as gold standard. Pak J Health Sci 2025;6(3):291-295. https://doi.org/10.54393/pjhs.v6i3.2685.
22. Wahid G, Tamkeen N, Maqsood F, et al. Diagnostic accuracy of ultrasound in detecting malignant thyroid nodules keeping histopathology as gold standard. J Postgrad Med Inst 2024;38(3):165-169.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
